Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Mode of action and clinical studies with alemtuzumab.
A questionnaire survey comparing the educational priorities of patients and medical students in the management of multiple sclerosis.
Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis.
Lipopolysaccharide treatment arrests the cell cycle of BV-2 microglial cells in G1 phase and protects them from UV light-induced apoptosis.
Diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy: a practical overview based on some case studies.
Clinical features in Guillain-Barré syndrome with anti-Gal-C antibody.
Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis.
Progressive multifocal leukoencephalopathy in patients with multiple sclerosis.
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis.
Transglutaminase 2 and neuroinflammation.
Evidence for a multiple sclerosis epidemic?
New drug for relapsing multiple sclerosis.
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis.
Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple Sclerosis Patients(♦).
MOBP-specific cellular immune responses are weaker than MOG-specific cellular immune responses in patients with multiple sclerosis and healthy subjects.
Inflammatory demyelinating diseases in children: an update.
Cognitive screening tools in multiple sclerosis revisited: sensitivity and specificity of a short version of Rao's Brief Repeatable Battery.
Association between neuromyelitis optica and tuberculosis in a Chinese population.
Multiple sclerosis: Sodium channel blocker protects axons in MS models.
Influence of body mass index on psychological and functional outcomes in patients with multiple sclerosis: a cross-sectional study.
Protective effects of N-acetyl-L-cysteine in human oligodendrocyte progenitor cells and restoration of motor function in neonatal rats with hypoxic-ischemic encephalopathy.
[Diet and multiple sclerosis].
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: Yes.
Serum Biomarker gMS-Classifier2: Predicting Conversion to Clinically Definite Multiple Sclerosis.

Pages